Dr. Lalintip Hocharoen is currently a process development specialist at National Biopharmaceutical Facility (NBF) where she has been involved in technology transfers in microbial platform technologies including DNA vaccines and therapeutic protein production as well as process development for GMP master cell bank productions. From her Ph.D studies, she has experience with protein expression using microbial fermentation technology and assays related to kinetics, protein characterization, and drug design.